Myocarditis in idiopathic inflammatory myopathies: serologic and clinical correlates in a single-center registry
Authors:
- Jorge Álvarez-TroncosoJÁJorge Álvarez-Troncoso
- Elena Refoyo-SalicioERElena Refoyo-Salicio
- Samuel Díaz-PlanellasSDSamuel Díaz-Planellas
- Sergio Carrasco-MolinaSCSergio Carrasco-Molina
- Clara Soto-AbánadesCSClara Soto-Abánades
- Elena Martínez-RoblesEMElena Martínez-Robles
- Belén Gutiérrez-SancerniBGBelén Gutiérrez-Sancerni
- Ángel Robles-MarhuendaÁRÁngel Robles-Marhuenda
- Ana Noblejas-MozoANAna Noblejas-Mozo
- Juan José Ríos-BlancoJRJuan José Ríos-Blanco
- 3 June 2026
- journal article
- research article
- Published by Springer Nature in Rheumatology International
- Vol. 46 (6) , 124
Abstract
To characterize the clinical and serological correlates of cardiovascular magnetic resonance (CMR)-confirmed myocarditis in idiopathic inflammatory myopathies (IIM), evaluate the diagnostic performance of high-sensitivity cardiac troponin I (hs-TnI), and quantify the independent prognostic impact of myocarditis relative to interstitial lung disease (ILD). Single-center retrospective cohort study (STROBE-compliant) of 142 consecutive adults with IIM (2019–2025). Myocarditis was confirmed by CMR according to the 2018 Lake Louise Criteria, performed both at diagnosis and during follow-up (with or without immunosuppression) upon clinical suspicion and/or elevated hs-TnI. Myositis-specific antibodies (MSA), myositis-associated antibodies (MAA), anti-Ro52 and antiphospholipid antibodies (aPL, Sydney criteria: ≥40 GPL/MPL units confirmed at ≥ 12 weeks) were systematically recorded. Associations were assessed with Fisher’s exact test and logistic regression; multivariable models were pre-specified as parsimonious (two predictors) given the limited event count. Overall survival was analyzed with Kaplan–Meier curves, the log-rank test and Cox proportional-hazards regression. Myocarditis was confirmed in 9/142 patients (6.3%), without significant association with IIM class (P = 0.303) or with the antisynthetase antibody subgroup (anti-Jo-1 + PL-12 + PL-7 + EJ; 5.8% vs. 6.7%, P = 1.000). In univariable analyses, myocarditis was associated with Raynaud phenomenon (OR 13.6, 95% CI 2.3–80.0), aPL positivity (OR 10.7, 95% CI 2.6–43.9), anti-Ro52 coexisting with MSA/MAA (OR 8.7, 95% CI 2.2–34.8), anti-PM/Scl (OR 7.1, 95% CI 1.6–30.3), fever (OR 7.1, 95% CI 1.6–30.3) and ILD (OR 4.7, 95% CI 1.1–20.3). hs-TnI was markedly higher in myocarditis (median 366 vs. 3.5 ng/L; P < 0.001) with an area under the receiver-operating characteristic curve (AUROC) of 0.91 (95% CI 0.83–0.98). In the event-constrained multivariable model, Raynaud phenomenon (adjusted OR 13.1, 95% CI 1.5–112.7) and aPL (adjusted OR 7.2, 95% CI 1.4–36.0) remained independently associated. All-cause mortality was higher in myocarditis (44% vs. 9%; OR 7.95, 95% CI 2.0–31.5; log-rank P = 0.030; univariable Cox HR 3.77, 95% CI 1.03–13.78; P = 0.044), and persisted after adjustment for ILD in the logistic model (adjusted OR 5.9, 95% CI 1.3–26.1; P = 0.020), whereas ILD attenuated to a non-significant trend (adjusted OR 2.9, 95% CI 0.9–9.2; P = 0.073). In this single-center retrospective cohort, IIM-associated myocarditis was consistently associated with Raynaud phenomenon, aPL positivity and anti-Ro52 coexistence, and was associated with higher mortality than ILD. These findings support hs-TnI-guided triage to CMR as part of systematic cardiac surveillance in IIM, pending multicenter confirmation.Keywords
This publication has 22 references indexed in Scilit:
- 2025 ESC Guidelines for the management of myocarditis and pericarditisEuropean Heart Journal, 2025
- Management of acute myocarditis: a systematic review of clinical practice guidelines and recommendationsEuropean Heart Journal - Quality of Care and Clinical Outcomes, 2024
- Myocarditis in anti-synthetase syndrome: clinical features and diagnostic modalitiesRheumatology, 2023
- Myocarditis in connective tissue diseases: an often-overlooked clinical manifestationRheumatology International, 2023
- Mechanisms of immunothrombosis and vasculopathy in antiphospholipid syndromeSeminars in Immunopathology, 2022
- Associations between cardiac and pulmonary involvement in patients with juvenile dermatomyositis—a cross-sectional studyRheumatology International, 2022
- Idiopathic inflammatory myopathiesNature Reviews Disease Primers, 2021
- Defining cardiac involvement in idiopathic inflammatory myopathies: a systematic reviewRheumatology, 2021
- The aetiopathogenic significance, clinical relevance and therapeutic implications of vasculopathy in idiopathic inflammatory myopathyRheumatology, 2021
- Cardiovascular Magnetic Resonance in Nonischemic Myocardial InflammationJACC, 2018